The Enterprise Value as of December 2024 (TTM) for Ascendis Pharma A/S (ASND) is 8.13B

According to Ascendis Pharma A/S’s latest financial reports and current stock price. The company's current Enterprise Value is 8.13B. This represents a change of 42.41% compared to the average of 5.71B of the last 4 quarters.

Ascendis Pharma A/S (ASND) Historical Enterprise Value (quarterly & annually)

How has ASND Enterprise Value performed in the past?

The mean historical Enterprise Value of Ascendis Pharma A/S over the last ten years is 3.46B. The current 8.13B Enterprise Value has changed 23.40% with respect to the historical average. Over the past ten years (40 quarters), ASND's Enterprise Value was at its highest in in the March 2024 quarter at 8.39B. The Enterprise Value was at its lowest in in the September 2024 quarter at 163.15M.

Ascendis Pharma A/S (ASND) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Ascendis Pharma A/S Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Ascendis Pharma A/S (ASND) Average Enterprise Value

How has ASND Enterprise Value performed in the past?

The current Enterprise Value of Ascendis Pharma A/S (ASND) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Ascendis Pharma A/S (ASND) Enterprise Value vs. Peers

How is ASND’s Enterprise Value compared to its peers?

Ascendis Pharma A/S’s Enterprise Value is greater than Apellis Pharmaceuticals, Inc. (4.18B), less than BeiGene, Ltd. (18.37B), greater than Akero Therapeutics, Inc. (1.72B), greater than Blueprint Medicines Corporation (6.11B), greater than Replimune Group, Inc. (905.14M), greater than Nuvalent, Inc. (5.52B), greater than Ventyx Biosciences, Inc. (109.78M), less than United Therapeutics Corporation (15.10B), greater than IVERIC bio, Inc. (5.13B), greater than Amylyx Pharmaceuticals, Inc. (208.45M), less than Karuna Therapeutics, Inc. (12.43B), greater than Day One Biopharmaceuticals, Inc. (851.01M), greater than Chinook Therapeutics, Inc. (2.63B), greater than DICE Therapeutics, Inc. (1.82B), greater than Pliant Therapeutics, Inc. (795.12M), greater than Crinetics Pharmaceuticals, Inc. (4.72B), greater than 89bio, Inc. (882.70M), greater than Madrigal Pharmaceuticals, Inc. (6.70B), greater than Arcellx, Inc. (4.09B), greater than Stoke Therapeutics, Inc. (450.01M),

Build a custom stock screener for Ascendis Pharma A/S (ASND) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ascendis Pharma A/S using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ascendis Pharma A/S (ASND) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ascendis Pharma A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.